National Health Investors (NYSE:NHI) Downgraded to Hold at Zacks Investment Research – MarketBeat

0
65

National Health Investors (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Other research analysts have also recently issued reports about the company. Mizuho cut National Health Investors from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $56.00 to $55.00 in a research report on Wednesday. KeyCorp upgraded National Health Investors from an “underweight” rating to a “sector weight” rating in a report on Monday, December 14th. BMO Capital Markets lowered National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 target price on the stock. in a report on Thursday, January 7th. ValuEngine lowered National Health Investors from a “hold” rating to a “sell” rating in a report on Thursday, October 1st. Finally, Berenberg Bank lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Wednesday, December 2nd. Three investment analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. National Health Investors presently has an average rating of “Hold” and an average price target of $65.63.

(Ad)

They called the 2020 crash 45 days early. Nobody expects what they’re predicting now…

NHI stock opened at $66.92 on Thursday. The company has a debt-to-equity ratio of 1.02, a current ratio of 13.13 and a quick ratio of 13.13. The stock has a market capitalization of $2.99 billion, a P/E ratio of 15.71 and a beta of 0.85. The business has a 50-day moving average of $67.72 and a 200-day moving average of $62.94. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.48). The firm had revenue of $84.30 million for the quarter, compared to analyst estimates of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.42 earnings per share. Equities analysts expect that National Health Investors will post 5.63 EPS for the current year.

In other news, Director Robert G. Adams bought 1,000 shares of the stock in a transaction dated Tuesday, November 17th. The shares were bought at an average price of $66.45 per share, for a total transaction of $66,450.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert G. Adams bought 2,000 shares of the stock in a transaction dated Monday, December 14th. The shares were purchased at an average price of $67.75 per share, for a total transaction of $135,500.00. The disclosure for this purchase can be found here. 5.74% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in NHI. Marshall Wace North America L.P. bought a new position in shares of National Health Investors during the first quarter worth approximately $31,000. Amundi Pioneer Asset Management Inc. grew its position in National Health Investors by 2.5% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 79,619 shares of the real estate investment trust’s stock worth $6,254,000 after buying an additional 1,960 shares in the last quarter. First Republic Investment Management Inc. acquired a new stake in National Health Investors during the second quarter worth approximately $240,000. Private Advisor Group LLC acquired a new stake in National Health Investors during the second quarter worth approximately $31,000. Finally, Sei Investments Co. grew its position in National Health Investors by 118.5% during the second quarter. Sei Investments Co. now owns 10,975 shares of the real estate investment trust’s stock worth $666,000 after buying an additional 5,953 shares in the last quarter. Institutional investors own 62.41% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More: Beige Book

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

8 Retail Stocks to Own For the Long Haul

There are more than 500 national retailers traded on the NYSE and the NASDAQ. Given the sheer number of big box stores, warehouse clubs, restaurant chains, and other retail stores listed on public markets, it can be hard to identify which retailers will outperform the market.

Fortunately, some of Wall Street’s top analysts have already done most of the work for us.

Every year, analysts issue approximately 4,200 distinct recommendations for retail companies. Analysts may not always get their “buy” ratings right, but it’s worth taking a hard look when several analysts from different brokerages and research firms are giving “strong-buy” and “buy” ratings to the same retailer.

This slide show lists the 8 retail companies with the highest average analyst recommendations from Wall Street’s equities research analysts over the last 12 months.

View the “8 Retail Stocks to Own For the Long Haul”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here